Zebley CC - Search Results

1

Cellular and molecular waypoints along the path of T cell exhaustion.

Lan X, Zebley CC, Youngblood B. Lan X, et al. Among authors: zebley cc. Sci Immunol. 2023 Sep;8(87):eadg3868. doi: 10.1126/sciimmunol.adg3868. Epub 2023 Sep 1. Sci Immunol. 2023. PMID: 37656775 Free PMC article. Review.

2

Epigenetic Maintenance of Acquired Gene Expression Programs during Memory CD8 T Cell Homeostasis.

Abdelsamed HA, Zebley CC, Youngblood B. Abdelsamed HA, et al. Among authors: zebley cc. Front Immunol. 2018 Jan 18;9:6. doi: 10.3389/fimmu.2018.00006. eCollection 2018. Front Immunol. 2018. PMID: 29403491 Free PMC article. Review.

3

Beta cell-specific CD8⁺ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes.

Abdelsamed HA, Zebley CC, Nguyen H, Rutishauser RL, Fan Y, Ghoneim HE, Crawford JC, Alfei F, Alli S, Ribeiro SP, Castellaw AH, McGargill MA, Jin H, Boi SK, Speake C, Serti E, Turka LA, Busch ME, Stone M, Deeks SG, Sekaly RP, Zehn D, James EA, Nepom GT, Youngblood B. Abdelsamed HA, et al. Among authors: zebley cc. Nat Immunol. 2020 May;21(5):578-587. doi: 10.1038/s41590-020-0633-5. Epub 2020 Mar 30. Nat Immunol. 2020. PMID: 32231298 Free PMC article.

4

Rewriting History: Epigenetic Reprogramming of CD8⁺ T Cell Differentiation to Enhance Immunotherapy.

Zebley CC, Gottschalk S, Youngblood B. Zebley CC, et al. Trends Immunol. 2020 Aug;41(8):665-675. doi: 10.1016/j.it.2020.06.008. Epub 2020 Jul 2. Trends Immunol. 2020. PMID: 32624330 Free PMC article. Review.

5

CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia.

Zebley CC, Brown C, Mi T, Fan Y, Alli S, Boi S, Galletti G, Lugli E, Langfitt D, Metais JY, Lockey T, Meagher M, Triplett B, Talleur AC, Gottschalk S, Youngblood B. Zebley CC, et al. Cell Rep. 2021 Nov 30;37(9):110079. doi: 10.1016/j.celrep.2021.110079. Cell Rep. 2021. PMID: 34852226 Free PMC article.

6

Mechanisms of T cell exhaustion guiding next-generation immunotherapy.

Zebley CC, Youngblood B. Zebley CC, et al. Trends Cancer. 2022 Sep;8(9):726-734. doi: 10.1016/j.trecan.2022.04.004. Epub 2022 May 13. Trends Cancer. 2022. PMID: 35570136 Free PMC article. Review.

7

Improving antitumor T cells.

Zebley CC, Youngblood B. Zebley CC, et al. Science. 2022 Nov 11;378(6620):598. doi: 10.1126/science.adf0546. Epub 2022 Nov 10. Science. 2022. PMID: 36356156

8

T cell TET2 disruption cuts the breaks on antitumor CAR T cell therapy.

Zebley CC, Youngblood B. Zebley CC, et al. Trends Immunol. 2023 Jun;44(6):397-398. doi: 10.1016/j.it.2023.03.008. Epub 2023 Mar 21. Trends Immunol. 2023. PMID: 36959018

9

Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis.

Abdelsamed HA, Moustaki A, Fan Y, Dogra P, Ghoneim HE, Zebley CC, Triplett BM, Sekaly RP, Youngblood B. Abdelsamed HA, et al. Among authors: zebley cc. J Exp Med. 2017 Jun 5;214(6):1593-1606. doi: 10.1084/jem.20161760. Epub 2017 May 10. J Exp Med. 2017. PMID: 28490440 Free PMC article.

10

In vitro Homeostatic Proliferation of Human CD8 T Cells.

Abdelsamed HA, Zebley CC, Youngblood B. Abdelsamed HA, et al. Among authors: zebley cc. Bio Protoc. 2017 Nov 20;7(22):e2619. doi: 10.21769/BioProtoc.2619. Bio Protoc. 2017. PMID: 29226183 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page